PROGRAM LIJEČNICI – Toraks 2021

Srijeda 19.5

Četvrtak 20.5

Petak 21.5

Subota 22.5

Srijeda 19.5

Četvrtak 20.5

Petak 21.5

Subota 22.5

	Srijeda, 19. Svibnja 2021. \| Wednesday, May 19th 2021 Voditelji \| Chairpersons: Latinka Basara, Gordana Pavliša, Nevenka Piskač-Živković, Joško Šemnički, Željko Čulina, Vilim Kolari
15:00-15:10	Žarko Vrbica Što možemo naučiti o egzacerbacijama KOPB u vrijeme pandemije COVID-19? What we can learn about COPD exacerbations during COVID-19 pandemic?
15:10-15:20	Nevenka Piskač Živković COVID-19 pneumonija i liječenje visokim protokom kisika COVID-19 pneumonia and High flow oxygen therapy (HFOT)
15:20-15:30	Gordana Pavliša Neutralizirajuća protutijela i konvalescentna plazma u liječenju COVID-19 bolesti Antiviral drugs and direct inhibitors in COVID-19 treatment
15:30-15:40	Ana-Marija Šola, Dina Rnjak Covid infekcija u pacijenata sa transplantiranim plućima Neutralizing antibodies and convalescent plasma in the treatment of COVID-19 disease
15:45-15:55	Ana Hećimović Kortikosteroidi u liječenju COVID-19 infekcije – znamo li kada i koliko dugo? Corticosteroids in treatment of COVID-19 infection – do we know when and for how long?
15:55-16:05	Marinko Artuković, Tomislav Perković Alergijske reakcije na cjepiva i cijepljenje alergičara protiv COVID-19 bolesti Allergic reactions to vaccines and vaccination of allergy patients with COVID-19 vaccine
16:05-16:15	Mateja Janković Makek Post-COVID sindrom – pregled osnovnih pojmova Post-COVID syndrome – overview of basic concepts
16:15-16:25	Sanda Škrinjarić-Cincar Hiperventilacija u simptomatskih bolesnika nakon akutnog COVID-19 Hyperventilation in symptomatic patients after acute COVID-19
16:25-16:35	Fedža Džubur Plućna embolija kod post-COVID-19 bolesnika Pulmonary embolism in post-COVID-19 patients
16:35-16:45	Tajana Jalušić Glunčić Post-COVID i plućna rehabilitacija Post-COVID and pulmonology rehabilitation
16:45-16:55	Goran Glodić Prikaz slučaja: Ekstrakorporalna membranska oksigenacija (ECMO) u kasnoj fazi akutne COVID-19 bolesti Case report: Extracorporeal membrane oxygenation (ECMO) in late stage acute COVID-19 disease
17:00-18:00	Simpozij – Sponzoriran Symposium Sponsored by Berlin – Chemie
	Moderator: Miroslav Samaržija Andrea Vukić Dugac Utjecaj pandemije COVID-19 na fizičku aktivnost KOPB bolesnika Impact of the COVID-19 pandemic on the physical activity of COPD patients Fedža Džubur Edoksaban u liječenju duboke venske tromboze (DVT) i plućne embolije (PE) te prevenciji ponavljajućih DVT-a i PE-a u odraslih: Pivotalno ispitivanje Hokusai-VTE Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrent DVT and PE in adults: Pivotal study of Hokusai-VTE
18:00-18:45	Simpozij – Sponzoriran Symposium Sponsored by Pfizer
	Gordana Pavliša Izavukonazol – preemptivne mogućnosti terapije invazivne aspergiloze i mukormikoze Isavuconazole Pre-emptive treatment options for invasive aspergillosis and mucormycosis Dražena Srdić Tromboembolijske komplikacije u onkoloških bolesnika – što možemo učiniti? Tromboembolic complications in cancer patients – what can we do ?
18:50-19:20	Simpozij – Sponzoriran Symposium Sponsored by Alkaloid
	Zagorka Boras Fovelid (levofloxacin) – kada, kome i zašto? Fovelid (levofloxacin) – when, whom and why?
19:20	Otvaranje kongresa \| Opening ceremony

	Četvrtak, 20. svibnja 2021. \| Thursday, May 20th 2021 Voditelji \| Chairpersons: Sanja Popović Grle, Ivan Gudelj, Robert Paro Vidolin, Marinko Artuković, Žarko Vrbica
09:00-09:20	Bojana Butorac-Petanjek Global Lung Function Initiative (GLI) referentne vrijednosti za testove plućne funkcije Global Lung Function Initiative (GLI) reference values for pulmonary function tests
09:20-09:50	Simpozij – Sponzoriran Symposium Sponsored by Swixx Biopharma
	Sanja Popović Grle Respiracijske alergije – prilike za etiološko liječenje Respiratory allergies – opportunities for etiological treatment
09:50-10:35	Simpozij – Sponzoriran Symposium Sponsored by Berlin – Chemie
	Radovan Zrilić Terapija održavanja kod bolesnika s trajnom astmom Maintenance therapy in patients with persistent asthma Dino Ilak Klinički aspekt liječenja KOPB-a trojnom fiksnom kombinacijom IKS/LABA/LAMA Clinical aspect of COPD treatment with triple fixed combination ICS/LABA/LAMA
10:40-11:10	Simpozij – Sponzoriran Symposium Sponsored by Berlin – Chemie
	Sanja Popović Grle Četiri godine iskustva u liječenju teške eozinofilne astme Four years of experience in the treatment of severe eosinophilic asthma
11:10-11:30	Pauza \| Break
11:30-12:30	Simpozij – Sponzoriran Symposium Sponsored by AstraZeneca
	Jelena Ostojić i Andrea Vukić Dugac Trixeo – treća sreća Trixeo – third luck Stav hrvatskih pulmologa o biološkim lijekovima za astmu, možemo li bolje? The attitude of Croatian pulmonologists about biological drugs for asth- ma, can we do better? Neven Tudorić Biologici u teškoj astmi – gdje smo i možemo li bolje? Biologics in severe asthma – where we are now and how to get better? Sanja Popović Grle Rezultati istraživanja o primjeni biološke terapije u Hrvatskoj Results of research on use of biological therapy in Croatia
12:30-13:30	Simpozij – Sponzoriran Symposium Sponsored by PLIVA
	Jelena Ostojić, Žarko Vrbica Adherencija u bolesnika s opstruktivnim plućnim bolestima: jučer, danas, sutra Adherence in patients with obstructive lung diseases: yesterday, today, tomorrow Andrea Vukić Dugac Rani KOPB – igra skrivača? Early COPD – hide and seek?
13:35-14:05	Simpozij – Sponzoriran Symposium Sponsored by Boehringer Ingelheim
	Sanja Popović Grle Dispnea i KOPB – prepoznavanje ranih simptoma bolesti Dyspnoea and COPD – recognition of the early symptoms of disease
14:05-15:00	Pauza \| Break
	Voditelji \| Chairpersons: Ljiljana Bulat-Kardum, Marija Gomerčić Palčić, Tajana Jalušić Glunčić, Sanda Škrinjarić-Cincar
15:00-16:00	Simpozij – Sponzoriran Symposium Sponsored by Providens
	Moderator: Miroslav Samaržija “Sitno je bitno” – nova paradigma It’s the little things that matter the most – a new paradigm Sanja Popović Grle ATLANTIS – putokaz u liječenju astme ATLANTIS – a roadmap in the treatment of asthma Dave Singh Trojna fiksna terapija s vrlo sitnim česticama – dobitna kombinacija Triple fixed therapy with extrafine particles – a winning combination
16:00-16:45	Simpozij – Sponzoriran Symposium Sponsored by Novartis
	Primjeri iz svakodnevne kliničke prakse u liječenju teške alergijske astme Examples from everyday clinical practice in treatment of severe allergic asthma Sanja Popović Grle Jedino anti-IgE protutijelo dostupno za liječenje teške alergijske astme The only anty-IgE antibody in treatment of severe allergic asthma Marina Lampalo Višegodišnje iskustvo u kliničkoj primjeni i sigurnosni profil lijeka Xolair Clinical application and safety profile of Xolair – our experinece
16:50-17:20	Simpozij – Sponzoriran Symposium Sponsored by PLIVA
	Biološka terapija teške astme Severe asthma and biologic therapy Sanja Popović Grle Kako procijeniti odgovor bolesnika? How to evaluate the response? Marina Lampalo Ishodi u kliničkoj praksi Outcomes in clinical practice
17:20-18:20	Simpozij – Sponzoriran Symposium Sponsored by Medis Adria
	Marija Gomerčić Palčić Uloga visokih doza inhalacijskih kortikosteroida u liječenju astme The role of high dose of ICS in the treatment of asthma Mirjana Turkalj Nezadovoljene potrebe u astmi: Trebamo li nove inovativne kombinacije? Unmeet need in asthma: Do we need new innovative combinations? Fedža Džubur Važnost redukcije dana hospitalizacije PAH pacijenata u vrijeme pandemije Importance of reduction in hospitalisation days of PAH patients in a time of pandemic
18:20-18:35	Ana Hećimović Tadalafil – nova terapijska opcija u liječenju PAH-a Tadalafil – a new therapeutic option in the treatment of PAH
18:40-19:25	Simpozij – Sponzoriran Symposium Sponsored by MSD
	Irene M. Lang Barbara Salobir Miroslav Samaržija Izazovi u dijagnostici i terapijskim rješenjima u liječenju KTEPH-a i PAH-a Challenges in diagnostics and therapeutic solutions in the treatment of CTEPH and PAH

	Petak, 21. svibnja 2021. \| Friday, May 21st 2021 Voditelji \| Chairpersons: Lovorka Batelja Vuletić, Dražena Srdić, Suzana Mladinov, Milena Peitl, Sanja Pleština
09:00-09:20	Ante Marušić Nacionalni program probira i ranog otkrivanja raka pluća – prva iskustva Nationwide lung cancer screening program – first experiences
09:20-09:40	Silvana Smojver-Ježek Nove smjernice za uzimanje i obradu torakalnih malih biopsija i citoloških uzoraka i njihov utjecaj na rad citologija New Guidelines for Collection and Handling of Thoracic Small Biopsy and Cytology Specimens and Implications for the Cytology Community
09:40-10:00	Simpozij – Sponzoriran Medical symposium sponsored by Roche
	Miroslav Samaržija Budućnost liječenja raka pluća The Future of Lung Cancer Treatment
10:00-10:30	Simpozij – Sponzoriran Symposium Sponsored by Takeda
	Dijagnostika i liječenje ALK+ raka pluća te raka pluća s insercijskim mutacijama u egzonu 20 EGFR gena Diagnostics and treatment of ALK+ lung cancer, and lung cancer harboring EGFR exon20 insertion mutations Miroslav Samaržija Biologija i prognoza ALK+ raka pluća te raka pluća s insercijskim mutacijama u egzonu 20 EGFR gena Biology and prognosis of ALK positive lung cancer, and lung cancer harboring EGFR exon 20 insertion mutations Marko Jakopović Kliničke odluke u liječenju bolesnika s ALK+ rakom pluća Clinical decisions in the treatment ALK+ lung cancer patients
10:30-11:15	Simpozij – Sponzoriran Symposium Sponsored by Pfizer
	Izazovi u liječenju bolesnika s ALK+ i ROS1+ rakom pluća nemalih stanica Treatment challenges of patients with ALK + and ROS1 + non-small cell lung cancer Marko Jakopović Ishodi liječenja bolesnika s ALK+ rakom pluća nemalih stanica – može li bolje? Treatment outcomes of patients with ALK + NSCLC – could it be better? Sanja Pleština Lorviqua (lorlatinib) – sljedeća linija liječenja bolesnika s ALK+ rakom pluća nemalih stanica Lorviqua (lorlatinib) – the next line of treatment for patients with ALK + NSCLC Sonja Badovinac Izazovi u liječenju bolesnika s ROS1+ rakom pluća nemalih stanica Challenges in the treatment of patients with ROS1 + NSCLC
11:15-11:45	Simpozij – Sponzoriran Symposium Sponsored by Boehringer Ingelheim
	Moderator: Marko Jakopović Marko Jakopović Nintedanib u okviru trenutnih terapijskih opcija kod adenokarcinoma pluća Nintedanib in the light of therapeutical options for lung adenocarcinoma Marta Koršić Produžimo vrijeme bez kemoterapije bolesnicima s NSCLC EGFR+ Let’s prolong the time without chemotherapy for patients with NSCLC EGFR+
11:45-12:15	Simpozij – Sponzoriran Symposium sponsored by Roche
	Pravi lijek za pravog bolesnika u pravo vrijeme – kako nam FoundationOne može pomoći? The right treatment for the right patient at the right time – how can FoundationOne help us? Moderator: Marko Jakopović Sonja Badovinac Preduvjeti za uspješno FoundationOne testiranje Prerequisites for successful FoundationOne testing Kristina Krpina Što nam je FoundationOne otkrio u praksi-iskustva Klinike za plućne bolesti Jordanovac What FoundationOne revealed to us in practice-experiences of the Clinic for Lung Diseases Jordanovac
12:15-13:30	Pauza \| Break
13:30-14:30	Simpozij – Sponzoriran Symposium Sponsored by MSD
	Miroslav Samaržija, Marko Jakopović, Tihana Boraska Jelavić Redefiniranje očekivanja preživljenja za bolesnike s rakom pluća Redefining survival expectations for lung cancer patients
14:30-15:00	Simpozij – Sponzoriran Symposium Sponsored by AstraZeneca
	Marko Jakopović, Joško Juričić Možemo li unaprijediti liječenje resektabilnog raka pluća nemalih stanica Can we improve treatment of resectable NSCLC
15:05-15:50	Simpozij – Sponzoriran Symposium Sponsored by BMS
	Miroslav Samaržija, Marijo Boban, Marko Jakopović Imunoterapija kod uznapredovalih torakalnih karcinoma Immunotherapy in advanced thoracic cancers
15:50-16:35	Simpozij – Sponzoriran Symposium sponsored by Roche
	Standardi u liječenju proširenog raka pluća Standards in metastatic lung cancer treatment Moderator: Marko Jakopović Sanja Pleština ALECENSA® i ROZLYTREK®: standard u prvoj liniji liječenja bolesnika s ALK+ i ROS1+ NSCLC-om ALECENSA® and ROZLYTREK®: standard in the first line of ALK+ and ROS1+ NSCLC treatment Ana Bačelić Gabelica TECENTRIQ® u drugolinijskom liječenju raka pluća nemalih stanica TECENTRIQ® in the second line treatment of NSCLC Marta Koršić TECENTRIQ® u liječenju raka pluća malih stanica TECENTRIQ® in the small-cell lung cancer treatment Marko Jakopović TECENTRIQ® u monoterapiji prvolinijskog liječenja raka pluća nemalih stanica TECENTRIQ® monotherapy in the first line treatment of NSCLC

	Subota, 22. svibnja 2021. \| Saturday, May 22nd 2021 Voditelji \| Chairpersons: Zoran Janevski, Fedža Džubur, Đivo Ljubičić, Igor Barković, Miroslav Samaržija
09:00-09:10	Dorian Hiršl Prva bilateralna transplantacija pluća u Hrvatskoj – prvi dio First bilateral lung transplantation in Croatia – part one
09:10-09:20	Tomislav Kopjar Prva bilateralna transplantacija pluća u Hrvatskoj – drugi dio First bilateral lung transplantation in Croatia – part two
09:20-09:30	Dina Rnjak Novi lijekovi u pulmologiji New drugs in pulmonology
09:30-09:50	Andrea Vukić Dugac Projekt “Škola kašlja” – rezultati istraživanja i predstavljanje algoritama za liječenje kašlja “Cough school” project – results of survey and presentation of cough treatment algorithm
09:55-10:40	Simpozij – Sponzoriran Symposium sponsored by Roche
	Pirfenidone – jučer, danas, sutra Pirfenidone – yesterday, today, tomorrow Moderator: Miroslav Samaržija Ana Hećimović 10 godina pirfenidona u kliničkoj praksi Ten years of Pirfenidone in clinical practice Jasna Tekavec Trkanjec Primjena Pirfenidona u fibrozirajućim plućnim bolestima Use of Pirfenidone in fibrosing lung disease
10:40-11:25	Simpozij – Sponzoriran Symposium Sponsored by Boehringer Ingelheim
	Moderator: Miroslav Samaržija Miroslav Samaržija Intersticijske bolesti pluća, poznato i nepoznato – uvod Interstitial lung diseases, known and unknown Jasna Tekavec Trkanjec Nintedanib u liječenju progresivnih fibrozirajućih intersticijskih bolesti pluća Nintedanib for the treatment of progressive fibrosing interstitial lung diseases Ana Hećimović Zašto nintedanib u IPF-u Why nintedanib in IPF
	Voditelji \| Chairpersons: Suzana Kukulj, Gordana Pavliša, Mateja Janković Makek, Irena Godić
11:25-11:35	Nagrada za najbolje postere Best poster awards